Summary
Novo Nordisk, the company behind weight-loss drugs Ozempic and Wegovy, is suing Hims & Hers for selling unapproved versions of its medications in the US. The legal action began after Hims & Hers launched a new weight-loss pill, which they now stopped selling. This lawsuit follows a trend of cheaper, unapproved weight-loss drugs increasing in the market.
Key Facts
- Novo Nordisk is a Danish company that makes weight-loss drugs.
- They filed a lawsuit against Hims & Hers for selling unauthorized versions of their drugs in the US.
- Hims & Hers announced they would stop selling their new weight-loss pill.
- After the lawsuit news, Hims & Hers' stock fell by 16%.
- Weight-loss drugs like Wegovy have become very popular recently.
- The FDA is taking action to limit compounding of unapproved weight-loss drugs.
- Compounding is when drug companies sell medication not approved by authorities for specific patient needs.
- Novo Nordisk is addressing a different issue related to an advertisement for its Wegovy pill with the FDA.
